Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan
· Delayed Price · Currency is JPY 1,656.00
+37.50 (2.32%)
Mar 10, 2026, 1:05 PM JST
Santen Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 520,625 | 484,047 | 559,190 | 424,342 | 490,898 | 608,810 | Upgrade
|
| Market Cap Growth | 8.32% | -13.44% | 31.78% | -13.56% | -19.37% | -17.96% | Upgrade
|
| Enterprise Value | 458,135 | 405,379 | 476,424 | 362,459 | 422,435 | 555,406 | Upgrade
|
| Last Close Price | 1618.50 | 1401.52 | 1484.82 | 1067.53 | 1124.04 | 1364.10 | Upgrade
|
| PE Ratio | 17.62 | 13.35 | 21.00 | - | 18.04 | 89.19 | Upgrade
|
| Forward PE | 14.30 | 14.12 | 17.09 | 25.03 | 16.26 | 21.32 | Upgrade
|
| PS Ratio | 1.81 | 1.61 | 1.85 | 1.52 | 1.84 | 2.44 | Upgrade
|
| PB Ratio | 1.84 | 1.70 | 1.83 | 1.45 | 1.46 | 1.98 | Upgrade
|
| P/TBV Ratio | 2.53 | 2.30 | 2.52 | 2.15 | 2.37 | 3.13 | Upgrade
|
| P/FCF Ratio | 14.65 | 8.92 | 8.83 | 21.36 | 17.11 | 17.56 | Upgrade
|
| P/OCF Ratio | 12.57 | 7.95 | 7.70 | 11.42 | 10.66 | 15.69 | Upgrade
|
| PEG Ratio | 1.91 | 2.79 | 2.79 | 2.79 | 2.79 | 3.56 | Upgrade
|
| EV/Sales Ratio | 1.59 | 1.35 | 1.58 | 1.30 | 1.59 | 2.23 | Upgrade
|
| EV/EBITDA Ratio | 7.66 | 6.12 | 6.77 | 6.90 | 7.98 | 7.90 | Upgrade
|
| EV/EBIT Ratio | 11.01 | 8.39 | 9.13 | 10.27 | 11.78 | 10.38 | Upgrade
|
| EV/FCF Ratio | 12.89 | 7.47 | 7.52 | 18.24 | 14.72 | 16.02 | Upgrade
|
| Debt / Equity Ratio | - | 0.12 | 0.11 | 0.12 | 0.10 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.52 | 0.49 | 0.69 | 0.62 | 0.14 | Upgrade
|
| Debt / FCF Ratio | - | 0.63 | 0.55 | 1.82 | 1.15 | 0.29 | Upgrade
|
| Net Debt / Equity Ratio | -0.22 | -0.21 | -0.20 | -0.07 | -0.15 | -0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.02 | -0.89 | -0.85 | -0.41 | -0.95 | -0.75 | Upgrade
|
| Net Debt / FCF Ratio | -1.73 | -1.08 | -0.95 | -1.09 | -1.74 | -1.52 | Upgrade
|
| Asset Turnover | 0.72 | 0.71 | 0.71 | 0.63 | 0.62 | 0.62 | Upgrade
|
| Inventory Turnover | 2.26 | 2.72 | 2.99 | 2.95 | 2.79 | 2.56 | Upgrade
|
| Quick Ratio | 1.73 | 1.90 | 2.00 | 1.85 | 1.91 | 2.02 | Upgrade
|
| Current Ratio | 2.68 | 2.58 | 2.55 | 2.38 | 2.39 | 2.63 | Upgrade
|
| Return on Equity (ROE) | 10.79% | 12.14% | 8.92% | -4.75% | 8.45% | 2.18% | Upgrade
|
| Return on Assets (ROA) | 6.46% | 7.14% | 7.61% | 5.01% | 5.20% | 8.25% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.88% | 15.46% | 18.05% | 12.64% | 10.12% | 11.99% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.00% | 15.00% | 15.20% | 10.60% | 9.90% | 16.50% | Upgrade
|
| Earnings Yield | 5.88% | 7.49% | 4.76% | -3.52% | 5.54% | 1.12% | Upgrade
|
| FCF Yield | 6.82% | 11.21% | 11.33% | 4.68% | 5.85% | 5.70% | Upgrade
|
| Dividend Yield | 2.35% | 2.57% | 2.22% | 3.00% | 2.85% | 2.05% | Upgrade
|
| Payout Ratio | 41.30% | 33.40% | 44.59% | - | 44.07% | 163.81% | Upgrade
|
| Buyback Yield / Dilution | 6.20% | 5.01% | 4.98% | 3.26% | -0.02% | -0.03% | Upgrade
|
| Total Shareholder Return | 8.55% | 7.58% | 7.20% | 6.25% | 2.83% | 2.02% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.